EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors
Urologix, Inc.:

We consent to the incorporation by reference in the registration statements on Form S-8 (File Nos. 333-185479, 333-11981, 333-41385, 333-84869, 333-53634, 333-82854 and 333-124939) of Urologix, Inc. of our report dated September 21, 2012 with respect to the balance sheet of Urologix, Inc. as of June 30, 2012, and the related statements of operations, shareholders’ equity, and cash flows for each of the years in the two-year period ended June 30, 2012, which report appears in the June 30, 2013 annual report on Form 10-K of Urologix, Inc.

Our report dated September 21, 2012 contains an explanatory paragraph that states that the Company has suffered recurring losses from operations and negative operating cash flows and has significant current obligations related to the Prostiva acquisition that raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of that uncertainty.

	/s/ KPMG LLP
Minneapolis, Minnesota
September 20, 2013